News
-
Clinical Research Leaders Discuss Clinical Outcomes, Assessments And Technology At Boston Congress
12/1/2011
Attendees of PHT’s largest-ever annual PRO and ePRO Congress made it clear that PRO and ePRO are efficient, accurate, and economical methods to collect data within clinical trial research and post-market studies.
-
ePRO Innovator PHT Corporation Launches Live Chat 24/7 Global Customer Support
11/18/2011
PHT Corporation continues to define the standard for global ePRO customer support with the launch of the first live chat line in the ePRO industry.
-
VeriStrat® Results Correlate With Survival Outcomes In Kidney Cancer Patients
10/18/2011
Data presented at the 10th International Kidney Cancer Symposium being held in Chicago, IL show that the pretreatment blood-based test, VeriStrat, was able to stratify renal cell carcinoma (RCC) patients treated with a combination of two targeted therapies, sunitinib (Sutent®) and erlotinib (Tarceva®), by survival outcomes.
-
Symfo International And Isis Innovation Announce A Unique Turnkey Solution For Patient Reported Outcomes (PRO) Operations
7/8/2011
Isis Outcomes, a part of Isis Innovation Ltd, and Symfo are applying their respective areas of expertise to offer Sponsors and CROs a unique service that will help Drug Development/Study Managers to assess and choose the right PRO measure – validating and deploying PRO instruments, and ensuring that the study will meet Regulatory Authorities requirements.
This website uses cookies to ensure you get the best experience on our website. Learn more